iShares Biotechnology ETF (IBB)

iShares Biotechnology ETF (IBB $170.00)
- $170.00 P/E (TTM): 22.46X Cap: $7.99B
- View IBB Profile
- View Questions on IBB

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Intuitive Surgical Inc. (ISRG $420.06)
- $420.06 P/E (TTM): 54.69X Cap: $148.76B
- View ISRG Profile
- View Questions on ISRG
Vertex Pharmaceuticals Incorporated (VRTX $435.17)
- $435.17 P/E (TTM): 28.11X Cap: $110.44B
- View VRTX Profile
- View Questions on VRTX
AbbVie Inc. (ABBV $202.78)
- $202.78 P/E (TTM): 85.4X Cap: $358.27B
- View ABBV Profile
- View Questions on ABBV
Johnson & Johnson (JNJ $221.43)
- $221.43 P/E (TTM): 20.07X Cap: $533.03B
- View JNJ Profile
- View Questions on JNJ
Eli Lilly and Company (LLY $966.99)
- $966.99 P/E (TTM): 41.33X Cap: $910.65B
- View LLY Profile
- View Questions on LLY
Merck & Company Inc. (MRK $111.28)
- $111.28 P/E (TTM): 15.3X Cap: $274.84B
- View MRK Profile
- View Questions on MRK
iShares Biotechnology ETF (IBB $170.00)
- $170.00 P/E (TTM): 22.46X Cap: $7.99B
- View IBB Profile
- View Questions on IBB
IDEXX Laboratories Inc. (IDXX $532.00)
- $532.00 P/E (TTM): 42.82X Cap: $41.96B
- View IDXX Profile
- View Questions on IDXX
Halozyme Therapeutics Inc. (HALO $66.41)
- $66.41 P/E (TTM): 25.34X Cap: $7.59B
- View HALO Profile
- View Questions on HALO
Incyte Corporation (INCY $100.32)
- $100.32 P/E (TTM): 15.38X Cap: $20.03B
- View INCY Profile
- View Questions on INCY
Catalyst Pharmaceuticals Inc. (CPRX $31.15)
- $31.15 P/E (TTM): 18.43X Cap: $3.80B
- View CPRX Profile
- View Questions on CPRX
Gilead Sciences CDR (CAD Hedged) (GILD $26.41)
- $26.41 P/E (TTM): 19.37X Cap: $222.19B
- View GILD Profile
- View Questions on GILD

Q: We have accumulated 11 healthcare stocks and 1 ETF, While LLY and ISRG are at half positions the rest are at initial 25% positions. Please advise [help!] us get to a more concentrated portfolio with a 3+ year horizon for reasonable opportunities in healthcare

Read Answer Asked by sam on January 13, 2026

iShares Biotechnology ETF (IBB $170.00)
- $170.00 P/E (TTM): 22.46X Cap: $7.99B
- View IBB Profile
- View Questions on IBB
State Street SPDR S&P Biotech ETF (XBI $134.75)
- $134.75 P/E (TTM): 17.96X Cap: $8.30B
- View XBI Profile
- View Questions on XBI
Natera Inc. (NTRA $199.14)
- $199.14 Cap: $28.51B
- View NTRA Profile
- View Questions on NTRA
ARK Genomic Revolution ETF (ARKG $29.94)
- $29.94 P/E (TTM): 27.48X Cap: $1.02B
- View ARKG Profile
- View Questions on ARKG
Catalyst Pharmaceuticals Inc. (CPRX $31.15)
- $31.15 P/E (TTM): 18.43X Cap: $3.80B
- View CPRX Profile
- View Questions on CPRX

Q: It looks like biotech stocks are on a tear, especially those that may benefit from AI. Do you have any names that you might recommend? I'm considering the Arkg fund but I don't quite trust Cathy Woods after losing money on the Arkk fund in 2021. Thank you,

Jason

Read Answer Asked by Jason on February 18, 2025

Biogen Inc. (BIIB $197.95)
- $197.95 P/E (TTM): 21.96X Cap: $29.22B
- View BIIB Profile
- View Questions on BIIB
Gilead Sciences Inc. (GILD $133.52)
- $133.52 P/E (TTM): 19.4X Cap: $165.77B
- View GILD Profile
- View Questions on GILD
Illumina Inc. (ILMN $142.51)
- $142.51 P/E (TTM): 25.94X Cap: $21.56B
- View ILMN Profile
- View Questions on ILMN
AbbVie Inc. (ABBV $202.78)
- $202.78 P/E (TTM): 85.4X Cap: $358.27B
- View ABBV Profile
- View Questions on ABBV
Abbott Laboratories (ABT $82.56)
- $82.56 P/E (TTM): 22.67X Cap: $143.80B
- View ABT Profile
- View Questions on ABT
Eli Lilly and Company (LLY $966.99)
- $966.99 P/E (TTM): 41.33X Cap: $910.65B
- View LLY Profile
- View Questions on LLY
Novo Nordisk A/S (NVO $46.40)
- $46.40 P/E (TTM): 12.75X Cap: $363.68B
- View NVO Profile
- View Questions on NVO
iShares Biotechnology ETF (IBB $170.00)
- $170.00 P/E (TTM): 22.46X Cap: $7.99B
- View IBB Profile
- View Questions on IBB
State Street SPDR S&P Biotech ETF (XBI $134.75)
- $134.75 P/E (TTM): 17.96X Cap: $8.30B
- View XBI Profile
- View Questions on XBI
First Trust NYSE Arca Biotechnology ETF (FBT $36.20)
- $36.20 P/E (TTM): 27.89X Cap: $3M
- View FBT Profile
- View Questions on FBT

Q: Hi 5i, can you give me the names of 4 or 5 large cap pharmaceutical companies that are buyable now. Also I'm looking for 4 or 5 Biotech companies with one drug in the market making money and maybe something in the pipeline that looks like it has a good future? for example TGTX.

Read Answer Asked by Mark on January 09, 2025